Beverly Wyse
Known title: DirectorCIK: 0002115872
Associated companies
Transaction History
| IPX | ▲ Buy | Option Exercise | 106,093 | $92K | 7/15/2026 | View on chart |
| IPX | ▲ Buy | Option Exercise | 106,093 | $92K | 7/15/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
IPX Gets Analyst Coverage, Second U.S. Army Task Order for Titanium
IperionX received a second task order from the U.S. Army focused on accelerating industrial-scale American titanium production, marking continued government engagement with the company's manufacturing capabilities. Separately, Jefferies initiated analyst coverage of the stock with a $26 price target, bringing more institutional attention to the company. The analyst consensus price target across six firms stands at $45.50, with individual targets ranging from $26 to $55. These developments signal growing both government and institutional interest in IperionX's domestic titanium production operations.
IPX Gets Analyst Coverage, Second U.S. Army Task Order for Titanium. IperionX received a second task order from the U.S. Army focused on accelerating industrial-scale American titanium production, marking continued government engagement with the company's manufacturing capabilities. Separately, Jefferies initiated analyst coverage of the stock with a $26 price target, bringing more institutional attention to the company. The analyst consensus price target across six firms stands at $45.50, with individual targets ranging from $26 to $55. These developments signal growing both government and institutional interest in IperionX's domestic titanium production operations.